Early Effector T Lymphocytes Coexpress Multiple Inhibitory Receptors in Primary Non-Small Cell Lung Cancer.

Abstract:

:Clinical efficacy of PD-1/PD-L1 targeting relies upon the reactivation of tumor-specific but functionally impaired PD-1+ T cells present before therapy. Thus, analyzing early-stage primary tumors may reveal the presence of T cells that are not yet functionally impaired. In this study, we report that activated (HLA-DR+) T cells with an effector memory (TEM) profile are enriched in such lesions. Tumor-infiltrating lymphocytes coexpressed PD-1 with the inhibitory receptors TIM-3, CTLA-4, LAG-3, and TIGIT, but also displayed a recently activated, nonexhausted phenotype. We also identified a subset of CD8+PD-1+FOXP3+ T lymphocytes at the earliest phase of functional differentiation after priming, termed "early effector cells" (EEC), which also exhibited an activated nonexhausted phenotype, but was less differentiated and associated with coexpression of multiple inhibitory receptors. In response to autologous tumor, EECs upregulated CD107a, produced IL2 and IFNγ, and were competent for differentiation. The identification of EECs marked by inhibitory receptor expression at tumor sites will enable investigations of early stages of adaptive antitumor immunity, as well as support the rationale for administering immunotherapy in early-stage non-small cell lung cancer. Cancer Res; 77(4); 851-61. ©2016 AACR.

journal_name

Cancer Res

journal_title

Cancer research

authors

Tassi E,Grazia G,Vegetti C,Bersani I,Bertolini G,Molla A,Baldassari P,Andriani F,Roz L,Sozzi G,Pastorino U,Mortarini R,Anichini A

doi

10.1158/0008-5472.CAN-16-1387

subject

Has Abstract

pub_date

2017-02-15 00:00:00

pages

851-861

issue

4

eissn

0008-5472

issn

1538-7445

pii

0008-5472.CAN-16-1387

journal_volume

77

pub_type

杂志文章
  • In vivo drug sensitivity assay of clonogenic human melanoma cells and correlation with treatment outcome.

    abstract::In vitro tests of tumor cell drug sensitivity have been suggested as a means of selecting more appropriate clinical strategies against human cancer and improving preclinical drug development. The lack of biotransformation in these in vitro assays precludes the meaningful assessment of several major chemotherapeutic ag...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kirkwood JM,Marsh JC

    更新日期:1983-07-01 00:00:00

  • A latent Mr 94,000 gelatin-degrading metalloprotease induced during differentiation of HL-60 promyelocytic leukemia cells: a member of the collagenase family of enzymes.

    abstract::The treatment of HL-60 promyelocytic leukemia cells with phorbol esters (12-O-tetradecanoylphorbol-13-acetate) results in the appearance of cell substrate adhesion and the release of a Mr 94,000 gelatin-degrading metalloprotease. The appearance of the metalloprotease in the culture medium directly correlates with the ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Davis GE,Martin BM

    更新日期:1990-02-15 00:00:00

  • Comparison of different busulfan analogues for depletion of hematopoietic stem cells and promotion of donor-type chimerism in murine bone marrow transplant recipients.

    abstract::Busulfan (1,4-butanediol dimethanesulfonate, BU) is relatively unique among other standard chemotherapy compounds in its ability to deplete noncycling primitive stem cells in the host and consequently to allow for high levels of long-term, donor-type engraftment after bone marrow transplantation (BMT). Such a property...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Westerhof GR,Ploemacher RE,Boudewijn A,Blokland I,Dillingh JH,McGown AT,Hadfield JA,Dawson MJ,Down JD

    更新日期:2000-10-01 00:00:00

  • Quantitative estimation of epidermal growth factor receptor and c-erbB-2 in human breast cancer.

    abstract::Epidermal growth factor receptor (EGFR) expression by human breast cancer has been shown to predict poor patient outcome, as has amplification of the c-erbB-2 proto-oncogene. We have developed a quantitative immunohistochemical method for measuring protein levels of both receptors and have applied this to a series of ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Robertson KW,Reeves JR,Smith G,Keith WN,Ozanne BW,Cooke TG,Stanton PD

    更新日期:1996-08-15 00:00:00

  • A gene hypermethylation profile of human cancer.

    abstract::We are in an era where the potential exists for deriving comprehensive profiles of DNA alterations characterizing each form of human cancer. Such profiles would provide invaluable insight into mechanisms underlying the evolution of each tumor type and will provide molecular markers, which could radically improve cance...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Esteller M,Corn PG,Baylin SB,Herman JG

    更新日期:2001-04-15 00:00:00

  • Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.

    abstract::Our previous study showed that spleen cells from BALB/c mice bearing RL male 1 lymphoma inhibited the growth of RL male 1 lymphoma by the Winn-type adoptive transfer assay. Although this antitumor activity was mediated by the T-cell subset manifesting the surface phenotype of cytotoxic T-lymphocytes (CTLs), this antit...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Fuyama S,Yamamoto H,Fujii Y,Arai S

    更新日期:1986-11-01 00:00:00

  • Interleukin-7-dependent expansion and persistence of melanoma-specific T cells in lymphodepleted mice lead to tumor regression and editing.

    abstract::Active-specific immunotherapy with dendritic cells loaded with peptide derived from the melanoma antigen, gp100, failed to mediate regression of established B16F10 melanoma in normal mice. Dendritic cell vaccination induced activation and subsequent deletion of adoptively transferred naive CD8+ T-cell receptor transge...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-2117

    authors: Wang LX,Li R,Yang G,Lim M,O'Hara A,Chu Y,Fox BA,Restifo NP,Urba WJ,Hu HM

    更新日期:2005-11-15 00:00:00

  • Serine Synthesis Helps Hypoxic Cancer Stem Cells Regulate Redox.

    abstract::Phosphoglycerate dehydrogenase (PHGDH) is the metabolic enzyme responsible for shunting the glycolytic intermediate 3-phosphoglycerate to the serine synthesis pathway. In breast cancer and several other types of cancer, increased PHGDH expression is associated with patient mortality. Early studies focused on the role ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-16-1730

    authors: Samanta D,Semenza GL

    更新日期:2016-11-15 00:00:00

  • Dose-dependent differences in the mutational profiles of (-)-(1R,2S,3S,4R)-3,4-dihydroxy-1, 2-epoxy-1,2,3,4-tetrahydrobenzo[c]phenanthrene and its less carcinogenic enantiomer.

    abstract::Chinese hamster V-79 cells were treated with high cytotoxic or low noncytotoxic concentrations of the highly carcinogenic and mutagenic (-)-(1R,2S,3S,4R)-3,4-dihydroxy-1, 2-epoxy-1,2,3,4-tetrahydrobenzo[c]phenanthrene [(-)-B[c]PhDE; fjord-region diol epoxide] or its biologically less active (+)-(1S,2R,3R,4S) enantiome...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Wei SJ,Chang RL,Cui XX,Merkler KA,Wong CQ,Yagi H,Jerina DM,Conney AH

    更新日期:1996-08-15 00:00:00

  • DeltaNp63alpha confers tumor cell resistance to cisplatin through the AKT1 transcriptional regulation.

    abstract::Strategies to address resistance to platin drugs are greatly needed in human epithelial cancers (e.g., ovarian, head/neck, and lung) where platins are used widely and resistance occurs commonly. We found that upon ΔNp63α overexpression, AKT1 and phospho-AKT1 levels are upregulated in cancer cells. Investigations using...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-1481

    authors: Sen T,Sen N,Brait M,Begum S,Chatterjee A,Hoque MO,Ratovitski E,Sidransky D

    更新日期:2011-02-01 00:00:00

  • Intracellular ATP levels determine cell death fate by apoptosis or necrosis.

    abstract::Although apoptosis and necrosis are morphologically distinct manifestations of cell death, apoptosis and some necroses share common features in the death signaling pathway involving functional steps of death-driving interleukin 1beta-converting enzyme family proteases and anti-cell death protein Bcl-2. One evident phy...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Eguchi Y,Shimizu S,Tsujimoto Y

    更新日期:1997-05-15 00:00:00

  • Induction of anchorage-independent growth of JB6 mouse epidermal cells by 1 alpha,25-dihydroxyvitamin D3.

    abstract::1 alpha,25-Dihydroxyvitamin D3 [1 alpha,25(OH)2D3], a hormonally active form of vitamin D3, was shown previously to enhance chemically induced transformation of BALB 3T3 cells and Syrian hamster embryo cells. This report demonstrates that 1 alpha,25(OH)2D3, like phorbol ester tumor promoters, induces anchorage-indepen...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hosoi J,Abe E,Suda T,Colburn NH,Kuroki T

    更新日期:1986-11-01 00:00:00

  • Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts.

    abstract::Amplification and rearrangement of the epidermal growth factor receptor (EGFR) gene are characteristics of many types of tumors. One class of EGFR mutations, EGFRvIII, is characterized by an in-frame deletion resulting in a truncated external domain of the receptor. EGFRvIII was first identified in a subset of gliomas...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Reist CJ,Archer GE,Kurpad SN,Wikstrand CJ,Vaidyanathan G,Willingham MC,Moscatello DK,Wong AJ,Bigner DD,Zalutsky MR

    更新日期:1995-10-01 00:00:00

  • Proteasome inhibition circumvents solid tumor resistance to topoisomerase II-directed drugs.

    abstract::Physiological cell conditions, such as glucose deprivation and hypoxia, play a role in developing drug resistance in solid tumors. These tumor-specific conditions cause decreased expression of DNA topoisomerase IIalpha (topo IIalpha), rendering cells resistant to topo II-targeted drugs, such as etoposide and doxorubic...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ogiso Y,Tomida A,Lei S,Omura S,Tsuruo T

    更新日期:2000-05-01 00:00:00

  • The plexin-A1 receptor activates vascular endothelial growth factor-receptor 2 and nuclear factor-kappaB to mediate survival and anchorage-independent growth of malignant mesothelioma cells.

    abstract::The semaphorins and their receptors, the neuropilins and the plexins, are constituents of a complex regulatory system that controls axonal guidance. Moreover, many types of tumor cells express various members of semaphorins and receptors, but the biological activities within tumor mass and the signal transduction mech...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-3659

    authors: Catalano A,Lazzarini R,Di Nuzzo S,Orciari S,Procopio A

    更新日期:2009-02-15 00:00:00

  • Novel mechanism of lapatinib resistance in HER2-positive breast tumor cells: activation of AXL.

    abstract::HER2-directed therapies, such as trastuzumab and lapatinib, are important treatments for breast cancer. However, some tumors do not respond or develop resistance to these agents. We isolated and characterized multiple lapatinib-resistant, HER2-positive, estrogen receptor (ER)-positive breast cancer clones derived from...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-4490

    authors: Liu L,Greger J,Shi H,Liu Y,Greshock J,Annan R,Halsey W,Sathe GM,Martin AM,Gilmer TM

    更新日期:2009-09-01 00:00:00

  • In vitro purging of human rhabdomyosarcoma cells using 4-hydroperoxycyclophosphamide.

    abstract::The outcome of patients with advanced stage rhabdomyosarcoma is extremely poor, with a disease-free survival of less than 20% at 3 years. Autologous bone marrow transplantation for patients with Clinical Group IV rhabdomyosarcoma may be an effective therapy. The bone marrow involvement diagnosed by light microscopy is...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ozkaynak MF,Nolta J,Parkman R

    更新日期:1990-03-01 00:00:00

  • Lethal and cytokinetic effects of anguidine on a human colon cancer cell line.

    abstract::Anguidine is a fungal metabolite with antitumor activity in a murine colon cancer model. Because of disappointing results in clinical trials, we analyzed the lethal and cytokinetic effects of anguidine on cultured human colon cancer cells. The studies revealed a moderate reduction in survival only after prolonged drug...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Dosik GM,Barlogie B,Johnston DA,Murphy WK,Drewinko B

    更新日期:1978-10-01 00:00:00

  • Targeting XRCC1 deficiency in breast cancer for personalized therapy.

    abstract::XRCC1 is a key component of DNA base excision repair, single strand break repair, and backup nonhomologous end-joining pathway. XRCC1 (X-ray repair cross-complementing gene 1) deficiency promotes genomic instability, increases cancer risk, and may have clinical application in breast cancer. We investigated XRCC1 expre...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-12-2929

    authors: Sultana R,Abdel-Fatah T,Abbotts R,Hawkes C,Albarakati N,Seedhouse C,Ball G,Chan S,Rakha EA,Ellis IO,Madhusudan S

    更新日期:2013-03-01 00:00:00

  • KEAP1 is a redox sensitive target that arbitrates the opposing radiosensitive effects of parthenolide in normal and cancer cells.

    abstract::Elevated oxidative stress is observed more frequently in cancer cells than in normal cells. It is therefore expected that additional exposure to a low level of reactive oxygen species (ROS) will push cancer cells toward death, whereas normal cells might maintain redox homeostasis through adaptive antioxidant responses...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-12-4297

    authors: Xu Y,Fang F,Miriyala S,Crooks PA,Oberley TD,Chaiswing L,Noel T,Holley AK,Zhao Y,Kiningham KK,Clair DK,Clair WH

    更新日期:2013-07-15 00:00:00

  • Reexpression of hSNF5 in malignant rhabdoid tumor cell lines causes cell cycle arrest through a p21(CIP1/WAF1)-dependent mechanism.

    abstract::Loss of hSNF5 function is usually observed in malignant rhabdoid tumor (MRT), a highly aggressive pediatric neoplasm. Previous studies have shown that reexpression of hSNF5 in MRT cell lines causes G1 cell cycle arrest with p16(INK4A), p21(CIP1/WAF1), and cyclin D1 playing key roles in MRT cell growth control. However...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-1922

    authors: Kuwahara Y,Charboneau A,Knudsen ES,Weissman BE

    更新日期:2010-03-01 00:00:00

  • Suppression of the negative regulator LRIG1 contributes to ErbB2 overexpression in breast cancer.

    abstract::The ErbB2 receptor tyrosine kinase is overexpressed in approximately 25% of breast tumors and contributes to poor patient prognosis and therapeutic resistance. Here, we examine the role of the recently discovered ErbB negative regulator LRIG1 in ErbB2(+) breast cancer. We observe that LRIG1 protein levels are signific...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-6316

    authors: Miller JK,Shattuck DL,Ingalla EQ,Yen L,Borowsky AD,Young LJ,Cardiff RD,Carraway KL 3rd,Sweeney C

    更新日期:2008-10-15 00:00:00

  • Cellular proliferation and ras oncogene of p21 21,000 expression in relation to the intracellular cyclic adenosine 3':5'-monophosphate levels of a human salivary gland adenocarcinoma cell line in culture.

    abstract::We have found that reversible differentiation into the myoepithelial cells of a human salivary gland adenocarcinoma cell line (HSG) occurs in growth medium containing dibutyryl cAMP (dB-cAMP). In the current study, the relationship between intracellular cAMP levels and anchorage-dependent and -independent growth or ra...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Azuma M,Yoshida H,Kawamata H,Yanagawa T,Furumoto N,Sato M

    更新日期:1988-05-15 00:00:00

  • Tumor necrosis factor stimulates epithelial tumor cell motility.

    abstract::Cellular motility is a critical function in embryonic development, tissue repair, and tumor invasion. We used assays of scattering (epithelial colony dispersion), cell migration, and cell invasion to study cytokine-regulated motility in epithelial and carcinoma cell lines. Tumor necrosis factor (TNF) stimulated motili...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Rosen EM,Goldberg ID,Liu D,Setter E,Donovan MA,Bhargava M,Reiss M,Kacinski BM

    更新日期:1991-10-01 00:00:00

  • Tissue changes resulting from the injection of gamma-irradiated cells into the gynogenetic teleost, Poecilia formosa.

    abstract::In previous studies a clone of the gynogenetic fish, Poecilia formosa (the Amazon molly), was successfully used as a test animal to identify ultraviolet-induced damage. This work has been extended, and the fish system was used to detect damage caused byionizing radiation. Fish cells, exposed in vitro to 250 and 500 ra...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Woodhead D,Setlow RB,Hart RW

    更新日期:1977-12-01 00:00:00

  • Expression of RASSF1A, an epigenetically silenced tumor suppressor, overcomes resistance to apoptosis induction by interferons.

    abstract::Resistance of human renal cell carcinoma (RCC) and melanoma to the apoptosis-inducing effects of IFNs was postulated to result from epigenetic silencing of genes by DNA methylation, a common feature of human cancers. To reverse silencing, 5-AZA-deoxycytidine (5-AZA-dC) or selective depletion of DNA methyltransferase 1...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-2303

    authors: Reu FJ,Leaman DW,Maitra RR,Bae SI,Cherkassky L,Fox MW,Rempinski DR,Beaulieu N,MacLeod AR,Borden EC

    更新日期:2006-03-01 00:00:00

  • Site-dependent differences in response of the UV-2237 murine fibrosarcoma to systemic therapy with adriamycin.

    abstract::Murine fibrosarcoma UV-2237MM cells were implanted into different organs of syngeneic C3H/HeN mice. The resultant tumors were treated by i.v. administration of Adriamycin (ADR). Despite the high sensitivity of the fibrosarcoma cells to ADR in vitro, the established tumors growing in vivo exhibited marked differences i...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Staroselsky AN,Fan D,O'Brian CA,Bucana CD,Gupta KP,Fidler IJ

    更新日期:1990-12-15 00:00:00

  • CD40 cross-linking bypasses the absolute requirement for CD4 T cells during immunization with melanoma antigen gene-modified dendritic cells.

    abstract::Genetic immunization of mice with dendritic cells (DCs) engineered to express a melanoma antigen generates antigen-specific, MHC-restricted, CD4-dependent protective immune responses. We wanted to determine the role of CD4 cells and CD40 ligation of MART-1 gene-modified DC in an animal model of immunotherapy for murin...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ribas A,Butterfield LH,Amarnani SN,Dissette VB,Kim D,Meng WS,Miranda GA,Wang HJ,McBride WH,Glaspy JA,Economou JS

    更新日期:2001-12-15 00:00:00

  • Indibulin, a novel microtubule inhibitor, discriminates between mature neuronal and nonneuronal tubulin.

    abstract::Microtubule inhibitors interfere with microtubule dynamics, causing cell cycle arrest and apoptosis. These effects are responsible for the chemotherapeutic activities of members of the taxane and Vinca alkaloid families in oncology. Unfortunately, a major side effect of the taxanes and Vinca alkaloids is the developme...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-1342

    authors: Wienecke A,Bacher G

    更新日期:2009-01-01 00:00:00

  • Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes.

    abstract::In this study, we performed high-resolution array comparative genomic hybridization with an array of 4153 bacterial artificial chromosome clones to assess copy number changes in 44 archival breast cancers. The tumors were flow sorted to exclude non-tumor DNA and increase our ability to detect gene copy number changes....

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-1992

    authors: Loo LW,Grove DI,Williams EM,Neal CL,Cousens LA,Schubert EL,Holcomb IN,Massa HF,Glogovac J,Li CI,Malone KE,Daling JR,Delrow JJ,Trask BJ,Hsu L,Porter PL

    更新日期:2004-12-01 00:00:00